Authors: Chmela, Z Vesely, J Lemr, K Rypka, M Hanus, J Havlicek, L Drystof, V Michnova, L Fuksova, K Lukes, J

Citation: Z. Chmela et al., In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependentkinase inhibitor bohemine in mice: Glucosidation as the principal metabolic route, DRUG META D, 29(3), 2001, pp. 326-334

Authors: Kubista, J Hanus, V Havlicek, L Hanus, J Halada, P Kuzma, M

Citation: J. Kubista et al., Rearrangement and loss of bromine radical and CO from some bromobenzyl alcohols following electron ionisation, EUR J MASS, 6(2), 2000, pp. 135-141

Authors: Otyepka, M Krystof, V Havlicek, L Siglerova, V Strnad, M Koca, J

Citation: M. Otyepka et al., Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2, J MED CHEM, 43(13), 2000, pp. 2506-2513

Authors: Stavreva, DA Strnad, M Havlicek, L Gichner, T

Citation: Da. Stavreva et al., SCGE analysis of genomic damage induced in cultured tobacco suspension cells by three purine analogues - Olomoucine, bohemine and roscovitine and by hydrogen peroxide, and ethyl methanesulfonate, NEOPLASMA, 46, 1999, pp. 92-93

Authors: Strnad, M Krystof, V Havlicek, L

Citation: M. Strnad et al., Control of tumour development in plants and animals: a comparative treatise, ADVANCES IN REGULATION OF PLANT GROWTH AND DEVELOPMENT, 1999, pp. 193-202